-
Use of skin, cheek cells may help monitor nomlabofusp effects in FA
Researchers may have found a less invasive way to monitor treatment response in Friedreich’s ataxia. A new study found that skin and cheek cells could help track the effects of nomlabofusp therapy, potentially giving scientists important insights without invasive biopsies.
Click here: https://bit.ly/4tyYUfl to read more about the findings.
-
0 Replies
Sorry, there were no replies found.
Log in to reply.